MedPage Today on MSN
FDA proposes new approval pathway for rare disease gene therapy
Will consider data that includes "the experience of individuals," FDA commissioner says ...
Light powers everything from communications to sensing, yet even tiny imperfections can scatter it and weaken signals. To ...
The framework, first introduced by FDA Commissioner Marty Makary and Center for Biologics Evaluation and Research head Vinay ...
FDA unveils pathway ultra-rare disease therapies to approve gene-editing and RNA treatments when trials are unfeasible for small populations.
Today, the FDA issued draft guidance outlining a new regulatory pathway intended to help sponsors gain approval for highly ...
After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...
WATE 6 On Your Side on MSN
FDA proposes new treatment approval pathway for ultra-rare diseases
The Food and Drug Administration (FDA) on Monday announced a new proposal for flexible drug approval pathway treatments ...
A team of researchers engineered a new strategy to convert carbon dioxide into industrially applicable chemicals. The study ...
The first part of the program focuses on the circular bioeconomy, the intersection of technology and agriculture.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results